JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

PARP

A4159 PJ34 hydrochloride

Summary: PARP inhibitor,potent and cell-permeable

insoluble in H2O; insoluble in EtOH; ≥16.6 mg/mL
A4158 AG-14361
1 Citation

Summary: Potent PARP1 inhibitor
A4157 Iniparib (BSI-201)

Summary: PARP1 inhibitor,intravenously adminsitered

insoluble in H2O; ≥103.4 mg/mL
A4156 Rucaparib (AG-014699,PF-01367338)
3 Citation

Summary: Potent PARP inhibitor

≥21.08 mg/mL
A4154 Olaparib (AZD2281, Ku-0059436)
30 Citation

Summary: PARP-1/2 inhibitor

≥21.72 mg/mL
A4153 BMN 673

Summary: Potent PARP inhibitor
A3958 Veliparib dihydrochloride

Target: PARP

Summary: PARP-1/PARP-2 inhibitor

≥31.7 mg/mL
A3729 PJ34

Target: PARP

Summary: PARP-l inhibitor

≥50.9 mg/mL
A3617 MK-4827

Target: PARP

Summary: PARP-1/-2 inhibitor,potent and selective

≥32 mg/mL
A3246 BMN-673 8R,9S
1 Citation

Summary: Inactive form of BMN 673, used as negative control

≥38 mg/mL